DK168423B1 - Stabilt, presset farmaceutisk præparat og fremgangsmåde til fremstilling deraf. - Google Patents

Stabilt, presset farmaceutisk præparat og fremgangsmåde til fremstilling deraf. Download PDF

Info

Publication number
DK168423B1
DK168423B1 DK653688A DK653688A DK168423B1 DK 168423 B1 DK168423 B1 DK 168423B1 DK 653688 A DK653688 A DK 653688A DK 653688 A DK653688 A DK 653688A DK 168423 B1 DK168423 B1 DK 168423B1
Authority
DK
Denmark
Prior art keywords
physiologically acceptable
ramipril
coated
pharmaceutical composition
alkyl
Prior art date
Application number
DK653688A
Other languages
Danish (da)
English (en)
Other versions
DK653688A (da
DK653688D0 (da
Inventor
Werner Fuelberth
Richard Leeb
Manfred Radau
Willi Stammberger
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK653688D0 publication Critical patent/DK653688D0/da
Publication of DK653688A publication Critical patent/DK653688A/da
Application granted granted Critical
Publication of DK168423B1 publication Critical patent/DK168423B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/40—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK653688A 1987-11-24 1988-11-23 Stabilt, presset farmaceutisk præparat og fremgangsmåde til fremstilling deraf. DK168423B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3739690 1987-11-24
DE19873739690 DE3739690A1 (de) 1987-11-24 1987-11-24 Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen

Publications (3)

Publication Number Publication Date
DK653688D0 DK653688D0 (da) 1988-11-23
DK653688A DK653688A (da) 1989-05-25
DK168423B1 true DK168423B1 (da) 1994-03-28

Family

ID=6341084

Family Applications (1)

Application Number Title Priority Date Filing Date
DK653688A DK168423B1 (da) 1987-11-24 1988-11-23 Stabilt, presset farmaceutisk præparat og fremgangsmåde til fremstilling deraf.

Country Status (21)

Country Link
US (2) US5151433A (cs)
EP (1) EP0317878B1 (cs)
JP (1) JPH0768140B2 (cs)
KR (1) KR970004908B1 (cs)
CN (1) CN1028962C (cs)
AT (1) ATE74513T1 (cs)
AU (1) AU615495B2 (cs)
CA (1) CA1338344C (cs)
DE (2) DE3739690A1 (cs)
DK (1) DK168423B1 (cs)
ES (1) ES2033400T3 (cs)
FI (1) FI93693C (cs)
GR (1) GR3004925T3 (cs)
HU (1) HU202100B (cs)
IE (1) IE61173B1 (cs)
IL (1) IL88460A0 (cs)
NO (1) NO176550C (cs)
NZ (1) NZ227032A (cs)
PH (1) PH27416A (cs)
PT (1) PT89061B (cs)
ZA (1) ZA888734B (cs)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US6300361B1 (en) 1990-07-25 2001-10-09 Novartis Ag Stabilized pharmaceutical compositions comprising acid donors
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
IL123636A (en) * 1995-12-27 2001-04-30 Janssen Pharmaceutica Nv Bioadhesive compounds, tablets containing them and a method of preparing the tablets
SE9903028D0 (sv) * 1999-08-27 1999-08-27 Astra Ab New use
DK1216038T3 (da) * 1999-08-30 2005-12-27 Sanofi Aventis Deutschland Anvendelse af inhibitorer af reninangiotensinsystemet ved forebyggelsen af cardiovaskulære hændelser
US20030225124A1 (en) * 1999-08-31 2003-12-04 Spiridon Spireas Stable formulations of ACE inhibitors, and methods for preparation thereof
FR2824477B1 (fr) * 2001-05-09 2005-09-09 Ethypharm Lab Prod Ethiques Granules enrobes a base d'inhibiteur de l'enzyme de conversion de l'anfiotensine, leur procede de preparation et comprimes orodispersibles contenant les granules enrobes
CA2357982A1 (en) * 2001-09-28 2003-03-28 Bernard Charles Sherman Solid compositions comprising ramipril
EP1467717A1 (en) * 2002-01-15 2004-10-20 Ranbaxy Laboratories Limited Stable pharmaceutical compositions comprising ace inhibitor(s)
EP1653929A1 (en) * 2003-01-22 2006-05-10 Sandoz AG Solid pharmaceutical composition comprising ramipril
GB0301471D0 (en) * 2003-01-22 2003-02-19 Biochemie Gmbh Organic compounds
CA2530788C (en) * 2003-06-26 2010-02-09 Teva Pharmaceutical Industries Ltd Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane-3-carboxylic acid derivatives
US6869963B2 (en) * 2003-07-11 2005-03-22 Sandoz Ag Stable pharmaceutical compositions containing an ACE inhibitor
WO2005041940A1 (en) * 2003-10-30 2005-05-12 Lupin Ltd. Stable formulations of ace inhibitors and methods for preparation thereof
GB2394660A (en) * 2003-12-17 2004-05-05 Niche Generics Ltd Stabilisation of pharmaceutical compositions comprising ACE inhibitor by absence of acidic excipients having large specific surface area, eg silicon dioxide
GB2411355B (en) * 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
EA011862B1 (ru) * 2004-03-24 2009-06-30 Актавис Груп Хф. Композиции рамиприла
US20060045911A1 (en) * 2004-08-27 2006-03-02 Sun Pharmaceutical Industries Ltd. Stable pharmaceutical formulations
BRPI0517663A (pt) * 2004-11-05 2008-10-14 King Pharmaceuticals Res & Dev composição farmacêutica, método para preparar a mesma, produto, e, método para tratar distúrbios cardiovasculares
WO2006048895A1 (en) * 2004-11-08 2006-05-11 Rubicon Research Pvt. Ltd. Aqueous pharmaceutical coating
GB0518129D0 (en) * 2005-09-06 2005-10-12 Arrow Int Ltd Ramipril formulation
KR100679166B1 (ko) 2005-10-04 2007-02-06 신풍제약주식회사 안정성이 증진된 약제학적 조성물 및 그의 제조방법
GB2431579A (en) * 2005-10-28 2007-05-02 Arrow Int Ltd Ramipril formulations
US20070098782A1 (en) * 2005-10-28 2007-05-03 Selamine Limited Ramipril Formulation
AU2007230234A1 (en) * 2006-03-28 2007-10-04 Gelesis, Inc. Use of polymeric materials with other substances for improved performance
US20070232680A1 (en) * 2006-04-04 2007-10-04 Vijayabhaskar Bolugoddu Preparation of ramipril and stable pharmaceutical compositions
MX2008013374A (es) * 2006-04-19 2008-11-12 Teva Pharma Composiciones farmaceuticas estables de derivados del acido 2-aza-biciclo[3.3.0]-octano-3-carboxilico.
EP1864677B1 (en) * 2006-06-02 2008-01-02 Teva Pharmaceutical Industries Ltd Stable formulation comprising a moisture sensitive drug and manufacturing procedure thereof
WO2007142628A1 (en) * 2006-06-02 2007-12-13 Teva Pharmaceutical Industries Ltd. Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof
US20070281000A1 (en) * 2006-06-02 2007-12-06 Michael Fox Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof
CA2653382A1 (en) * 2006-06-30 2008-01-03 Alphapharm Pty Ltd A stabilised composition comprising ace inhibitors
KR20090042976A (ko) * 2006-08-28 2009-05-04 사노피-아벤티스 도이칠란트 게엠베하 글루코즈 수준을 저하시키는 방법
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
PL382311A1 (pl) * 2007-04-27 2008-11-10 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Kompozycja farmaceutyczna o polepszonej stabilności zawierająca inhibitor acetylocholinoesterazy lub farmaceutycznie dopuszczalną jego sól oraz sposób jej wytwarzania
AU2009228832A1 (en) 2008-03-28 2009-10-01 Ferrer Internacional S.A. Capsule for the prevention of cardiovascular diseases
US20100062062A1 (en) * 2008-09-11 2010-03-11 Aethos Pharmaceuticals, Inc. Stabilized Coating for Pharmaceutical Formulations
TR200906322A2 (tr) 2009-08-17 2011-07-21 Bi̇lgi̇ç Mahmut Çözünürlük ve stabilite özellikleri geliştirilmiş granüller.
ES2364011B1 (es) 2009-11-20 2013-01-24 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
HK1205683A1 (en) 2012-02-17 2015-12-24 埃吉斯药物私人有限公司 Pharmaceutical formulation having improved stability
PL227900B1 (pl) 2012-11-15 2018-01-31 Adamed Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja farmaceutyczna zawierająca inhibitor ACE i bloker kanałów wapniowych, sposób jej wytwarzania i jednostka dawkowania zawierająca tę kompozycję
HUP1300496A2 (hu) 2013-08-16 2015-03-02 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Stabil kombinációs gyógyszerkészítmény
TWI668285B (zh) * 2015-12-31 2019-08-11 長興材料工業股份有限公司 可熱聚合之組合物、由此形成之組成液及其用途
EP3275432A1 (en) 2016-07-25 2018-01-31 H e x a l Aktiengesellschaft Dosage form with ace inhibitor
RS66060B1 (sr) 2020-02-10 2024-11-29 Adamed Pharma S A Sastav koji sadrži ramipril i indapamid
CN115068434B (zh) * 2022-08-03 2023-05-09 昆山龙灯瑞迪制药有限公司 一种雷米普利片的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3565559A (en) * 1968-03-11 1971-02-23 Sumitomo Chemical Co Process for making microcapsules
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
DE3039073A1 (de) * 1980-10-16 1982-05-19 Röhm GmbH, 6100 Darmstadt Umhuelltes acetylsalicylsaeurepraeparat
ATE20469T1 (de) * 1980-10-23 1986-07-15 Schering Corp Carboxyalkyl-dipeptide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
US4425355A (en) * 1981-02-17 1984-01-10 Warner-Lambert Company Substituted acyl derivatives of chair form of octahydro-1H-indole-2-carboxylic acids
DE3226768A1 (de) * 1981-11-05 1983-05-26 Hoechst Ag, 6230 Frankfurt Derivate der cis, endo-2-azabicyclo-(3.3.0)-octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung
EP0153105B1 (en) * 1984-02-10 1992-09-09 Benzon Pharma A/S Diffusion coated multiple-units dosage form
DE3413710A1 (de) * 1984-04-12 1985-10-24 Hoechst Ag, 6230 Frankfurt Verfahren zur behandlung der herzinsuffizienz
AU4104085A (en) * 1984-04-13 1985-10-17 Macewans Machinery Ltd. Steam-heated beater
CA1259924A (en) * 1985-03-25 1989-09-26 Wallace E. Becker Pharmaceutical tableting method
DE3610391A1 (de) * 1986-03-27 1987-10-08 Hoechst Ag Verbindungen mit nootroper wirkung, diese enthaltende mittel und deren verwendung bei der behandlung und prophylaxe cognitiver dysfunktionen
GB8616669D0 (en) * 1986-07-09 1986-08-13 Merk Sharpe & Dohme Ltd Pharmaceutical compositions
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
CA1323833C (en) * 1987-04-28 1993-11-02 Yatindra M. Joshi Pharmaceutical compositions in the form of beadlets and method
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
US4898732A (en) * 1988-05-04 1990-02-06 The Clinipad Corporation Inhibiting of tumor growth with an antagonist of the renin-angioten-sin system

Also Published As

Publication number Publication date
HUT48455A (en) 1989-06-28
GR3004925T3 (cs) 1993-04-28
ATE74513T1 (de) 1992-04-15
AU615495B2 (en) 1991-10-03
IE883505L (en) 1989-05-24
FI885398A0 (fi) 1988-11-22
KR890007739A (ko) 1989-07-05
KR970004908B1 (ko) 1997-04-08
ES2033400T3 (es) 1993-03-16
CA1338344C (en) 1996-05-21
PT89061A (pt) 1988-12-01
DK653688A (da) 1989-05-25
CN1042917A (zh) 1990-06-13
PT89061B (pt) 1993-03-31
JPH0768140B2 (ja) 1995-07-26
NO176550C (no) 1995-04-26
IE61173B1 (en) 1994-10-05
DK653688D0 (da) 1988-11-23
EP0317878A1 (de) 1989-05-31
IL88460A0 (en) 1989-06-30
US5151433A (en) 1992-09-29
HU202100B (en) 1991-02-28
NO176550B (no) 1995-01-16
DE3869919D1 (de) 1992-05-14
EP0317878B1 (de) 1992-04-08
DE3739690A1 (de) 1989-06-08
US5442008A (en) 1995-08-15
FI93693C (fi) 1995-05-26
PH27416A (en) 1993-06-21
CN1028962C (zh) 1995-06-21
NO885213L (no) 1989-05-25
AU2581888A (en) 1989-05-25
FI93693B (fi) 1995-02-15
FI885398A7 (fi) 1989-05-25
NO885213D0 (no) 1988-11-23
JPH01165596A (ja) 1989-06-29
NZ227032A (en) 1991-05-28
ZA888734B (en) 1989-07-26

Similar Documents

Publication Publication Date Title
DK168423B1 (da) Stabilt, presset farmaceutisk præparat og fremgangsmåde til fremstilling deraf.
US4404183A (en) Sustained release pharmaceutical composition of solid medical material
KR100348842B1 (ko) 염기성물질로안정화된약제학적조성물
CA2301185C (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
EA029890B1 (ru) Фармацевтическая композиция и фармацевтическая композиция в пероральной дозированной лекарственной форме на основе ингибитора dpp iv
KR20120064141A (ko) 코팅된 정제 제형 및 방법
JP2013063982A (ja) バルデナフィル塩酸塩三水和物を含む薬剤
CZ261494A3 (en) Pharmaceutical preparation for oral application and process for preparing thereof
KR20140014398A (ko) 고형 제약학적 조성물 및 이들의 생산 방법
KR102080023B1 (ko) 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물
KR102494141B1 (ko) 프로톤 펌프 저해제 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물 및 이의 제조방법
KR101136655B1 (ko) 레보타이록신 나트륨을 포함하는 제약 제제
CZ236798A3 (cs) Farmaceutické přípravky obsahující cilansetron stabilizované proti racemizaci
KR20080112387A (ko) 2-아자-비사이클로[3.3.0]-옥탄-3-카르복실산 유도체의 안정한 약학 조성물
KR102533637B1 (ko) 화합물과 푸마르산의 결정체, 코로나바이러스 유발 질환의 치료를 위한 약학적 조성물 및 방법
JP2009519985A (ja) （ｅ）−７−〔４−（４−フルオロフェニル）−６−イソプロピル−２−〔メチル（メチルスルホニル）アミノ〕ピリミジン−５−イル〕−（３ｒ，５ｓ）−３，５−ジヒドロキシヘプタ−６−エン酸を含む医薬組成物
JP2001354566A (ja) ニセルゴリンの錠剤
JP5563371B2 (ja) クエチアピンフマル酸塩含有経口用錠剤
KR20200002486A (ko) 습식과립 조성물, 이를 함유하는 정제 및 정제의 제조 방법
TR2023018145A2 (tr) Geli̇şti̇ri̇lmi̇ş çözünme hizina sahi̇p mi̇kofenolat mofeti̇l fi̇lm kapli tablet formülasyonlari i̇çi̇n üreti̇m yöntemi̇
BRPI0621739A2 (pt) formulação estável que consiste em drogas sensìveis à umectação e seu procedimento de fabricação
EP4456983A1 (en) Pharmaceutical compositions comprising macitentan as active ingredient and other relevant excipients
TW202432125A (zh) 含替格列汀粒子及包含其之製劑
CN111759850A (zh) 草酸替诺福韦的药物组合物
HU215191B (hu) Eljárás Levodopa és Carbidopa hatóanyag-kombinációt tartalmazó, szabályozott hatóanyag-leadású, központi dopaminhiányos állapotok kezeléséhez alkalmas orális gyógyszerkészítmény előállítására

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired